相关实验视频
Updated: Jul 1, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.7K
机器学习对血栓缺血风险和通过血小板溶解脂和甲类物种的出血事件的洞察力
Tobias Harm1, Xiaoqing Fu2, Moritz Frey1
1Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Otfried-Müller-Straße 10, 72076, Tübingen, Germany.
Scientific reports
|March 14, 2024
概括
鲜明的血小板脂质有助于预测冠状动脉疾病 (CAD) 患者的心血管风险. 通过机器学习分析血小板脂组学,可以比传统因素更好地评估风险.
科学领域:
- 心血管医学 心血管医学
- 利皮多米克 (Lipidomics) 是一种消化剂.
- 机器学习 机器学习
背景情况:
- 冠状动脉疾病 (CAD) 造成了重大负担,传统的风险因素不足以进行全面的心血管风险评估.
- 血小板在动脉动脉进展中发挥作用,它们的脂质概况可能表明CAD患者的疾病严重程度.
研究的目的:
- 调查血小板脂类物种与CAD患者心血管风险之间的关联.
- 评估机器学习模型的实用性,将血小板脂组学和临床数据整合起来,以改善心血管风险分层.
主要方法:
- 通过质谱测量,从595名CAD患者的队列中获得了脂管学数据.
- 机器学习模型使用CV风险测量和临床参数训练了表型风险组.
- 血小板脂质与常规风险因素一起分析,以评估不良心血管事件的诊断准确性.
主要成果:
- 特定的血小板脂被确定为增加心血管或出血风险和不良事件的独立预测因素.
- 将血小板脂质数据与传统风险因素相结合,显著提高了不良心血管事件的诊断准确性.
- 结合血小板脂组和临床数据的机器学习模型显示,在CAD中风险歧视的诊断价值增加.
结论:
- 异常的血小板脂质标志和功能与CAD患者心血管不良事件的风险增加有关.
- 整合血小板脂组学的机器学习方法可以改善心血管疾病中心血管事件的早期风险歧视和分类.
- 血小板脂质分析是完善冠状动脉疾病中心血管风险评估的有希望的生物标志物.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Anticoagulant Drugs: Low-Molecular-Weight Heparins
692
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
692
Formation of the Platelet Plug
6.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.1K
Clot Retraction and Fibrinolysis
5.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.8K

